Top

Indian Journal of Surgical Oncology

Published in:

01-03-2016 | ORIGINAL ARTICLE

Postoperative Morbidity and Mortality Following D2 Gastrectomy-an Audit of 456 Cases

Authors: Bhanu Jayanand Sunil, Ramakrishnan Ayloor Seshadri, Vikash Mahajan, Hemanth Raj Ellusami

Published in: Indian Journal of Surgical Oncology | Issue 1/2016

Abstract

Background

D2 gastrectomy is routinely performed in Japanese centres for carcinoma stomach with low morbidity and mortality. There were concerns in Western centres with regard to D2 gastrectomy in view of high morbidity and mortality rates. This study was aimed to study the postoperative morbidity and mortality following D2 gastrectomy for carcinoma stomach in a high volume centre in India.

Methods

It was a retrospective analysis of all the patients who underwent D2 gastrectomy from 1991 to 2010.

Results

D2 gastrectomy was performed in 456 patients during this period. Respiratory events were the most common cause of morbidity in the study group (2.4 %). Male gender (p = 0.007), presence of gastric outlet obstruction (p = 0.01) and pathological T4 (p = 0.05) independently predicted increased post operative morbidity in multivariate analysis. The morbidity and mortality rates declined with increase in hospital volume and experience of the surgeon.

Conclusion

D2 gastrectomy for carcinoma stomach can be performed safely in specialized centres with low morbidity and mortality rates.

Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy–Japan clinical oncology group study 9501. J Clin Oncol 22(14):2767–2773CrossRefPubMed

Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata S, Yamamoto H, Kim BS, Matsuki N, Sawa T (2006) Noh SH; east asia surgical oncology group. operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. HepatoGastroenterology 53(69):389–394PubMed

Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the mrc randomised controlled surgical trial. Surg Coop Group Lancet 347(9007):995–999

Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449CrossRefPubMed

Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30(3):303–308CrossRefPubMed

Bozzetti F, Chiappa A, Luca F, et al. (1997) Total versus subtotal gastrectomy: surgical morbidity and mortality in a multicenter Italian randomized trial. Ann Surg 226:613–620CrossRefPubMedPubMedCentral

Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF (2000) Is gastric carcinoma different between Japan and the United States? Cancer 89(11):2237–2246CrossRefPubMed

Portanova M, Vargas F, Lombardi E, Mena V, Carbajal R, Palacios N, Orrego J (2007) Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer 10(2):92–97CrossRefPubMed

Imamura H, Kurokawa Y, Kawada J, Tsujinaka T, Takiguchi S, Fujiwara Y, Mori M, Doki Y (2010) Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg 16

10.

Sah BK, Chen MM, Yan M, Zhu ZG (2010) Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital. World J Gastroenterol 16(1):98–103PubMedPubMedCentral

11.

Luna A, Rebasa P, Navarro S, Montmany S, Coroleu D, Cabrol J, Colomer O (2009) An evaluation of morbidity and mortality in oncologic gastric surgery with the application of POSSUM, P-POSSUM, and O-POSSUM. World J Surg 33(9):1889–1894CrossRefPubMed

12.

Gong DJ, Miao CF, Bao Q, Jiang M, Zhang LF, Tong XT, Chen L. Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy. World J Gastroenterol. 2008;14(42):6560–6563.

13.

Gil-Rendo A, Hernández-Lizoain JL, Martínez-Regueira F, Sierra Martínez A, Rotellar Sastre F, Cervera Delgado M, Valentí Azcarate V, Pastor Idoate C, Alvarez-Cienfuegos J (2006) Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 8(5):354–361CrossRefPubMed

14.

Díaz de Liaño A, Yárnoz C, Aguilar R, Artieda C, Ortiz H (2008) Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit. Cir Esp. 83(1):18–23CrossRefPubMed

15.

Kostić Z, Cuk V, Ignjatović M, Usaj-Knezević S (2006) Early complications following radical surgical treatment of patients with gastric adenocarcinoma. Vojnosanit Pregl 63(3):249–256CrossRefPubMed

16.

Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B (2006) Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 93(5):394–400CrossRefPubMed

17.

Kan YF, Zheng Y, Li SY, Liu J, Chen G, Han DD, Gao ZG (2005) Postoperative mortality after gastrectomy for gastric cancer: analysis of 1142 cases. Zhonghua Wei Chang Wai Ke Za Zhi 8(5):422–424PubMed

18.

Orsenigo E, Tomajer V, Palo SD, Carlucci M, Vignali A, Tamburini A, Staudacher C. Impact of age on postoperative outcomes in 1118 gastric cancer patients undergoing surgical treatment. Gastric Cancer. 2007;10(1):39–44.

19.

Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata memorial hospital: indian data can now be incorporated in future international trials. Dig Surg 23(3):192–197CrossRefPubMed

20.

Min CM, Sah BK, Xin YX, Meng YQ, Chen L, Ming X, Jun C, Min Y, Gang ZZ (2010) Why the postoperative mortality rate of gastric cancer is lower in our center? Hepato-Gastroenterology 57(97):178–184PubMed

21.

Pedrazzani C, Marrelli D, Rampone B, De Stefano A, Corso G, Fotia G, Pinto E, Roviello F (2007) Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer. Dig Dis Sci 52(8):1757–1763CrossRefPubMed

22.

Sierzega M, Kolodziejczyk P (2010) Kulig J; polish gastric cancer study group. impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg 97(7):1035–1042CrossRefPubMed

23.

Tanizawa Y, Bando E, Kawamura T, Tokunaga M, Ono H, Terashima M. Early postoperative anastomotic hemorrhage after gastrectomy for gastric cancer. Gastric Cancer. 2010;13(1):50–57.

24.

Ichikawa D, Kurioka H, Yamaguchi T, Koike H, Okamoto K, Otsuji E, Shirono K, Shioaki Y, Ikeda E, Mutoh F, Yamagishi H (2004) Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepato-Gastroenterology 51(56):613–617PubMed

25.

Lo CH, Chen JH, Wu CW, Lo SS, Hsieh MC, Lui WY. Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg. 2008;196(5):741–5.

26.

Mohri Y, Tonouchi H, Miki C, Kobayashi M (2008) Kusunoki M; Mie Surgical Infection Research Group. Incidence and risk factors for hospital-acquired pneumonia after surgery for gastric cancer: results of prospective surveillance. World J Surg 32(6):1045–1050CrossRefPubMed

27.

Suehiro T, Hirashita T, Araki S, Matsumata T, Tsutsumi S, Mochiki E, Kato H, Asao T, Kuwano H (2008) Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepato-Gastroenterology 55(86–87):1636–1639PubMed

28.

Tsujimoto H, Ichikura T, Ono S, Sugasawa H, Hiraki S, Sakamoto N, Yaguchi Y, Yoshida K, Matsumoto Y, Hase K (2009) Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol 16(2):311–318CrossRefPubMed

29.

Imai E, Ueda M, Kanao K, Miyaki K, Kubota T, Kitajima M (2005) Surgical site infection surveillance after open gastrectomy and risk factors for surgical site infection. J Infect Chemother 11(3):141–145CrossRefPubMed

30.

Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ (2005) Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 92(9):1099–1102CrossRefPubMed

31.

32.

Wu CW, Chang IS, Lo SS, Hsieh MC, Chen JH, Lui WY, Whang-Peng J (2006) Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World J Surg 30(1):12–16CrossRefPubMed

33.

Jeong O, Park YK, Ryu SY, Kim YJ (2010) Effect of age on surgical outcomes of extended gastrectomy with d2 lymph node dissection in gastric carcinoma: prospective cohort study. Ann Surg Oncol 17(6):1589–1596CrossRefPubMed

34.

Fatouros M, Roukos DH, Lorenz M, Arampatzis I, Hottentrott C, Encke A, Kappas AM (2005) Impact of spleen preservation in patients with gastric cancer. Anticancer Res 25(4):3023–3030PubMed

35.

Park SH, Mok YJ, Kim JH, Park SS, Kim SJ, Kim CS (2009) Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach. J Surg Oncol 100(3):215–221CrossRefPubMed

Title: Postoperative Morbidity and Mortality Following D2 Gastrectomy-an Audit of 456 Cases
Authors: Bhanu Jayanand Sunil
Ramakrishnan Ayloor Seshadri
Vikash Mahajan
Hemanth Raj Ellusami
Publication date: 01-03-2016
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 1/2016
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-015-0440-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Postoperative Morbidity and Mortality Following D2 Gastrectomy-an Audit of 456 Cases

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Assessment of Tumor Response and Resection Rates in Unresectable Colorectal Liver Metastases Following Neoadjuvant Chemotherapy with Cetuximab

Isolated Metastasis in Male Breast from Differentiated Thyroid Carcinoma – Oncological Curiosity. A Case Report and Review of Literature

HER2 Expression in Gastric Adenocarcinoma—a Study in a Tertiary Care Centre in South India

Chemotherapy Compared with Best Supportive Care for Metastatic/Unresectable Gallbladder Cancer: a Non-randomized Prospective Cohort Study

Chest Wall Infantile Fibrosarcomas- A Rare Presentation

Mucocele of the Appendix: Dilemmas in Differential Diagnosis and Therapeutic Management